Ludovic Deriano
Principal Investigator
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Non-homologous end joining (NHEJ) is the primary pathway for repairing G1 phase-induced DNA double-strand breaks (DSBs) during immunoglobulin heavy chain ( Igh ) class switch recombination (CSR) in B lymphocytes. In B cells lacking NHEJ (XRCC4) or DSB end protection (SHLD1), end joining during CSR proceeds through an alternative end-joining pathway. Polymerase theta (Pol θ) is widely regarded as a mediator of this pathway, essential for repairing replication-associated DSBs during mitosis when homologous recombination is unavailable. In this study, we examined CSR in primary B cells lacking XRCC4, SHLD1, and/or Pol θ, revealing two repair pathways: Pol θ-independent productive switching and Pol θ-dependent unproductive switching characterized by end resection, inversion and microhomology. Furthermore, we show that Pol θ-mediated repair under NHEJ-deficiency coincides with G1-to-S phase transition and occurs independently of RHINO and PLK1. Thus, in the absence of NHEJ, Pol θ repairs persistent G1-phase DSBs during S-phase rather than mitosis.
Year:
2025
Antigen receptor diversity depends on the assembly of variable (V), diverse (D), and joining (J) exons in genes encoding immunoglobulins (Igs) and T cell receptors (TCRs). During V(D)J recombination, DNA double-strand breaks (DSBs) introduced by the RAG1/2 nuclease complex are repaired by the process of nonhomologous end-joining (NHEJ). We hypothesized that functional redundancies between NHEJ and the chromatin DSB response, which depends on the kinase ATM, potentially masked the activity of additional factors that regulate V(D)J recombination. We performed targeted CRISPR-Cas9 knockout screens for genes implicated in V(D)J recombination in pro-B cells that were either untreated or treated with an ATM inhibitor. We found that loss of the RNA/DNA helicase senataxin (SETX) impaired V(D)J recombination and led to the formation of aberrant hybrid joints between coding ends and signal ends, both in vitro and in mice. The loss of SETX in a background deficient in the NHEJ factor XLF or in which ATM was inhibited led to substantial impairment of V(D)J recombination and to the presence of unsealed coding ends. SETX limited aberrant activation-induced cytidine deaminase (AID)–induced DNA end-joining between Igh -containing alleles during the process of class-switch recombination. Together, our findings reveal a previously uncharacterized role for SETX in promoting recombination fidelity during antigen receptor gene diversification.
Year:
2025
Downstream of 53BP1‐RIF1 lies the Shieldin (SHLD) protein complex, which comprises MAD2L2/REV7, SHLD3, SHLD2, and SHLD1, and the CTC1‐STN1‐TEN1 (CST) complex. During immunoglobulin heavy‐chain ( Igh ) class switch recombination (CSR), 53BP1‐RIF1‐SHLD promotes productive end‐joining by limiting resection of activation‐induced cytidine deaminase (AID)‐generated DNA double‐strand break (DSB) ends. The precise role of the CST complex and its interplay with SHLD during CSR is however elusive. Here, we established AID‐inducible B cell lines deficient for CTC1, SHLD1, or both and analyzed CSR in these cells. We show that stimulated CTC1‐deficient B cells are defective for IgM‐to‐IgA class switching, accumulate Igh chromosome breaks and translocations, and display increased end‐resection and micro‐homology usage at switching sites, demonstrating that CTC1 is essential to suppress alternative end‐joining during CSR. We show that CTC1 and SHLD1 are epistatic in preventing exacerbated DNA end resection and genetic instability during CSR. Moreover, using a complementation approach in Shld1 knockout splenic B cells, we show that a SHLD1 mutant defective in CST binding (SHLD1 ΔLDLP ) is fully proficient for IgM‐to‐IgG1, IgG2b, IgG3, and IgA class switching, thus demonstrating that the SHLD1‐CTC1 interaction through this motif is dispensable for CST and SHLD functions in promoting CSR.
Year:
2025
Year:
2023
Collaborators (7)
Nicolas Boissel
Université Paris Cité
Pedro Henrique de Lima Prata
MCU-PH
Université de Limoges
Gabriel Balmus
Principal Investigator
University of Cambridge
Richard Frock
Assistant Professor
Stanford University School of Medicine
Christophe Antoniewski
Sorbonne Université
Stéphanie Gachet
Chercheuse contractuelle
INSERM
Aaron Mendez-Bermudez
INSERM
Make your next move.
Prepare your application
Review drafts before you send them.